» Articles » PMID: 30840892

Fasting-Mimicking Diet Modulates Microbiota and Promotes Intestinal Regeneration to Reduce Inflammatory Bowel Disease Pathology

Overview
Journal Cell Rep
Publisher Cell Press
Date 2019 Mar 7
PMID 30840892
Citations 115
Authors
Affiliations
Soon will be listed here.
Abstract

Dietary interventions are potentially effective therapies for inflammatory bowel diseases (IBDs). We tested the effect of 4-day fasting-mimicking diet (FMD) cycles on a chronic dextran sodium sulfate (DSS)-induced murine model resulting in symptoms and pathology associated with IBD. These FMD cycles reduced intestinal inflammation, increased stem cell number, stimulated protective gut microbiota, and reversed intestinal pathology caused by DSS, whereas water-only fasting increased regenerative and reduced inflammatory markers without reversing pathology. Transplants of Lactobacillus or fecal microbiota from DSS- and FMD-treated mice reversed DSS-induced colon shortening, reduced inflammation, and increased colonic stem cells. In a clinical trial, three FMD cycles reduced markers associated with systemic inflammation. The effect of FMD cycles on microbiota composition, immune cell profile, intestinal stem cell levels and the reversal of pathology associated with IBD in mice, and the anti-inflammatory effects demonstrated in a clinical trial show promise for FMD cycles to ameliorate IBD-associated inflammation in humans.

Citing Articles

The cyclic metabolic switching theory of intermittent fasting.

Mattson M Nat Metab. 2025; .

PMID: 40087409 DOI: 10.1038/s42255-025-01254-5.


Acute tuft cell ablation in mice induces malabsorption and alterations in secretory and immune cell lineages in the small intestine.

Momoh M, Adeniran F, Ramos C, DelGiorno K, Seno H, Roland J Physiol Rep. 2025; 13(5):e70264.

PMID: 40051209 PMC: 11885799. DOI: 10.14814/phy2.70264.


Orphan G protein-coupled receptor GPRC5B controls macrophage function by facilitating prostaglandin E receptor 2 signaling.

Kwon J, Kawase H, Mattonet K, Guenther S, Hahnefeld L, Shamsara J Nat Commun. 2025; 16(1):1448.

PMID: 39920161 PMC: 11805951. DOI: 10.1038/s41467-025-56713-0.


Intermittent Fasting Reduces Intestinal Inflammation in Dextran Sulfate Sodium-Induced Colitis of Mice.

Song S, Zhang X, Zheng H, Liao Y, Tang P, Liu Y Food Sci Nutr. 2025; 13(2):e70014.

PMID: 39898122 PMC: 11787962. DOI: 10.1002/fsn3.70014.


Management of Overweight and Obesity in Patients With Inflammatory Bowel Disease.

Shneyderman M, Freid H, Kohler D, Peraza J, Haskey N, Abbott E Gastroenterol Hepatol (N Y). 2025; 20(12):712-722.

PMID: 39886003 PMC: 11776002.


References
1.
Brockmann L, Giannou A, Gagliani N, Huber S . Regulation of T17 Cells and Associated Cytokines in Wound Healing, Tissue Regeneration, and Carcinogenesis. Int J Mol Sci. 2017; 18(5). PMC: 5454945. DOI: 10.3390/ijms18051033. View

2.
Chassaing B, Aitken J, Malleshappa M, Vijay-Kumar M . Dextran sulfate sodium (DSS)-induced colitis in mice. Curr Protoc Immunol. 2014; 104:15.25.1-15.25.14. PMC: 3980572. DOI: 10.1002/0471142735.im1525s104. View

3.
Sartor R . Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol. 2006; 3(7):390-407. DOI: 10.1038/ncpgasthep0528. View

4.
Whibley N, Gaffen S . Gut-Busters: IL-17 Ain't Afraid of No IL-23. Immunity. 2015; 43(4):620-2. PMC: 4804829. DOI: 10.1016/j.immuni.2015.10.001. View

5.
Lichtenstein G . Comprehensive review: antitumor necrosis factor agents in inflammatory bowel disease and factors implicated in treatment response. Therap Adv Gastroenterol. 2013; 6(4):269-93. PMC: 3667472. DOI: 10.1177/1756283X13479826. View